Noom vs Embody: how the two GLP-1 programs compare on medicine, price and support

The short version

The medicine: compounded vs branded

This is the most important difference, and it's easy to miss in the marketing.

Embody lists no branded GLP-1s. The GLP-1s in its online catalog are compounded semaglutide and compounded tirzepatide. Its homepage says: "Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality." Its FAQ says the medicines come from state-licensed 503A compounding pharmacies.

Noom offers both. Its microdose plans use compounded semaglutide and tirzepatide, which Noom says are "not reviewed by the FDA for safety, efficacy, or quality." Noom also sells a telehealth plan for branded medicines, such as Wegovy or Zepbound, where the medicine is filled at a pharmacy and paid for separately or through insurance.

What the FDA says about compounded GLP-1s matters here. The agency says a compounded drug might be appropriate when a patient's needs can't be met by an FDA-approved drug, but that compounded drugs are not FDA-approved, so it "does not review compounded drugs for safety, effectiveness or quality before they are marketed." The FDA has also flagged:

• Reports of adverse events, some needing hospitalization, that may be tied to dosing errors with compounded injectable semaglutide.
• Salt forms of semaglutide, such as semaglutide sodium, that are different active ingredients from the approved drugs.
• Shipments that arrived warm, which can affect quality. The FDA recommends not using an injectable GLP-1 that arrives warm.
• Fraudulent products with fake pharmacy labels.

None of this means every compounded product is unsafe. It means you're relying on the pharmacy and the program, not the FDA, for quality. Our Noom microdose GLP-1 guide goes deeper on what "microdose" means.

Price: what each site posted, as of October 29, 2026

Both companies change prices often and run promotions, so check the checkout page before you commit. Each price below links to the company's own page and is dated.

Embody:

• 12-month plans: Embody's homepage showed a "flat rate" of $49 a month for weekly semaglutide injections and $99 a month for weekly tirzepatide injections, under a "Pre-Black Friday Sale" banner (as of October 29, 2026; Embody homepage). Embody's own product pages show those are the per-month rates on a 12-month supply: $588 for twelve months of semaglutide and $1,188 for twelve months of tirzepatide (as of October 29, 2026; Embody semaglutide 12-month page, Embody tirzepatide 12-month page).
• One-month plans: $79 for semaglutide and $129 for tirzepatide, shown as sale prices against a listed regular price of $299 and $349 (as of October 29, 2026; Embody semaglutide one-month page, Embody tirzepatide one-month page).
• Three-month plan: $228 for three months of semaglutide (as of October 29, 2026; Embody semaglutide three-month page).
• Embody's FAQ says your price doesn't go up if your dose changes within the same medicine. Pricing varies by plan length: 4, 12, 24 or 52 weeks.

Noom:

• Microdose GLP-1 Rx: $79 to start, then $179 a month after the first 4-week supply, billed quarterly. Medicine, clinical care and the program are included (as of October 29, 2026; Noom pricing page). Noom's own pages aren't consistent: its microdose page FAQ says it "starts at $49," and a footnote on the same page describes "$79/month, billed as $537 for 12-weeks" (as of October 29, 2026; Noom Microdose GLP-1 Rx page).
• GLP-1 Rx Plus (tirzepatide): $149 to start, then $299 a month, billed quarterly (as of October 29, 2026; Noom pricing page).
• Telehealth for branded medicines: $39 to start, then $129 a month, billed quarterly. The medicine itself isn't included (as of October 29, 2026; Noom pricing page).
• Metformin plan: $69 to start, then $99 a month. Noom notes metformin isn't FDA-approved for weight loss (as of October 29, 2026; Noom pricing page).

Noom also lists a standard GLP-1 Rx tier that starts at $129 (as of October 29, 2026; Noom pricing page). Check that page for its current monthly rate.

One caution: footnotes on Noom's homepage listed different, higher recurring rates for new accounts, marked "New pricing for new accounts only effective as of March 31, 2026" (as of October 29, 2026; Noom homepage). The two Noom pages didn't match when we checked, so confirm the rate at checkout before you enroll.

On sticker price, Embody's posted rates are lower. But you're comparing compounded medicine at both, unless you choose Noom's branded telehealth plan, where you'll also pay for the medicine or use insurance.

Support and coaching

Noom is a habit-change program first. Its GLP-1 plans include 1:1 coaching, a psychology-based curriculum, daily lessons, food logging and weight tracking. If you want to know who the coaches are, our guide to whether Noom coaches are certified covers it.

Embody focuses on the medicine. It offers 24/7 messaging with its care team and optional care coaching, which it describes as "education, motivation, and accountability." It says its coaches "are not clinicians," and that coaching is free and optional.

If you've used Noom before and it didn't stick, our guide to why Noom isn't working may help you figure out what to change.

Whichever program you choose, daily habits still do a lot of the work. Olive is a health companion that checks in with you every day, looks at what you eat, and helps you build small habits that actually hold. It doesn't diagnose or treat anything, so medicine questions still belong with a licensed clinician.

Cancellation terms

Read these before you sign up, because both sell multi-week plans.

• Embody's homepage says cancellation requests must arrive at least 72 hours before your next billing date, and that payments already made, including any charge inside that 72-hour window, are non-refundable.
• Embody's FAQ says you can cancel any time before your next medication shipment to avoid the next charge. That's not the same wording as the homepage, so confirm the rule with Embody in writing.
• Noom says you can "cancel anytime" on its microdose plans, but bills them quarterly. Check what a cancellation covers mid-quarter before you enroll.

Results claims

Both sites show weight-loss numbers. Embody says its claims refer to "self-reported data" from customers. Noom's figures are also based on self-reported data from its users. Self-reported results aren't the same as a controlled clinical trial, so treat them as marketing, not a prediction.

Which one fits?

• You want branded, FDA-approved medicine: Noom's telehealth plan for branded drugs, or your own doctor, is the route. Embody doesn't list branded options.
• You want the lowest posted monthly price and are comfortable with compounded medicine: Embody's posted rates were lower as of October 29, 2026, but check what's a promotion and how many months you're paying for.
• You want structured habit coaching alongside medicine: Noom's program is built around it.
• You live in Alabama, Louisiana or Mississippi: Noom says its microdose program isn't available there.
• You're still comparing apps without medicine: see our list of apps like Noom.

Whatever you pick, talk with a licensed clinician about whether a GLP-1 is right for you, and don't change your dose on your own.

This comparison is general information, not medical advice. Prices and terms were checked on October 29, 2026 and may change.

Keep the habits steady

Medicine is one part of the picture. Olive checks in with you every day and helps you build small habits that actually hold, with or without a GLP-1.

See how Olive works →